1984
DOI: 10.1016/s0140-6736(84)92324-9
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Lipopolysaccharide Immunotherapy in Management of Septic Shock of Obstetric and Gynaecological Origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
24
0

Year Published

1985
1985
2002
2002

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 118 publications
(24 citation statements)
references
References 12 publications
0
24
0
Order By: Relevance
“…Moreover, antilipopolysaccharide did reduce the recovery period of survivors in the treated group compared with the placebo group, as has been seen in other similar studies. 6 These results indicate the need for further similar studies in neonatal septicaemia, using antilipopolysaccharide antibodies given intravenously. These are currently being prepared at the Natal Institute of Immunology.…”
Section: Discussionmentioning
confidence: 93%
“…Moreover, antilipopolysaccharide did reduce the recovery period of survivors in the treated group compared with the placebo group, as has been seen in other similar studies. 6 These results indicate the need for further similar studies in neonatal septicaemia, using antilipopolysaccharide antibodies given intravenously. These are currently being prepared at the Natal Institute of Immunology.…”
Section: Discussionmentioning
confidence: 93%
“…For a blood bank collecting 200 units/day this yield provides 7% x 200/day x 5 days/week x 50 weeks = 3,500 anti-LPS-rich plasma units/ year. Our experience is that the antibodies in approximately 6 units of such plasma are therapeutic for severe gram-negative septic shock in humans [11]. Therefore 580 adult doses can be prepared per year.…”
Section: Mouse Protectionmentioning
confidence: 99%
“…We partially solved this problem by recognising that significant numbers of blood units donated to a blood bank contain raised levels of anti-LPS antibodies [6], de veloping an ELISA procedure to rapidly screen donated blood, retaining and pooling those units with high concentrations of anti-LPS [9]. Such human anti-LPS was protec tive in animals against septic abortion [10] and in humans against septic shock [7,11], We report here on the properties of a gamma globulin (lot LG-1) prepared from such high titre human plasma.…”
Section: Introductionmentioning
confidence: 99%
“…There have been three approaches to the development of passive immunization to endotoxin: (i) use of pooled blood bank plasma rich in anti-LPS (6,13,14), (ii) use of pooled immunoglobulin from volunteers immunized with an E. coli J5 boiled cell vaccine (2,19), and (iii) use of mouse (8,9) or human (5,12,18) monoclonal antibodies to E. coli J5.…”
mentioning
confidence: 99%